Targeting stem cells in triple-negative breast cancer

[News]

New research from the University of Michigan Comprehensive Cancer Center and Georgia Regents University finds that a protein that fuels an inflammatory pathway does not turn off in breast cancer, resulting in an increase in cancer stem cells. This provides a potential target for treating triple negative breast cancer, the most aggressive form of the disease.

More... (http://www.medicalnewstoday.com/releases/272788.php)